Clinically validated pathology-based AI prediction of ACE2 expression as a predictive biomarker of COVID-19 mortality | Demiurge Technologies

“As the world’s first AI-biopharma company that has discovered and publicized the precise aetiology and pathology of COVID-19, we are committed to the non-profit dissemination of our COVID-19 discoveries and the public validation of our COVID-19 clinical predictions.”

Read the full article @ Demiurge Technologies:

311 thoughts on “Clinically validated pathology-based AI prediction of ACE2 expression as a predictive biomarker of COVID-19 mortality | Demiurge Technologies”

Leave a Reply

Your email address will not be published. Required fields are marked *